Effect of selenium and n-acethylcysteine antioxidants on superoxide dismutase enzyme.
Phase 4
- Conditions
- Sever Trauma.
- Registration Number
- IRCT20201109049317N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age older than 18 year
Severe trauma patients need to admit in an Intensive Care Unit
Exclusion Criteria
Incomplete demographic information
Preexisting conditions
Sepsis and organ failure
Drug sensitivity
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Superoxide dismutase. Timepoint: 3 days after drug infusion. Method of measurement: Superoxide Dismutase Assay Kit.
- Secondary Outcome Measures
Name Time Method Organ function. Timepoint: 3 days after drug infusion. Method of measurement: APACHI 2.;Level of concsiousness. Timepoint: 3days after drug infusion. Method of measurement: Glasco Coma Scale.;Duration of hospitalization. Timepoint: Days of hospitalization after drug infusion. Method of measurement: Days of hospitalization.